Quick Takeaways
- Frazier Life Sciences Public Fund, L.P. filed SCHEDULE 13D/A for MBX BIOSCIENCES, INC. Common Stock, $0.0001 par value per share (MBX).
- Disclosed ownership: 12%.
- Date of event: 26 Sep 2025.
Quoteable Key Fact
"Frazier Life Sciences Public Fund, L.P. disclosed 12% ownership in MBX BIOSCIENCES, INC. Common Stock, $0.0001 par value per share (MBX) on 26 Sep 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 2.5% | 1,103,920 | 0 | 1,103,920 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P. | 0001863769 |
| FHMLSP, L.P. | 2.5% | 1,103,920 | 0 | 1,103,920 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P. | 0001879466 |
| FHMLSP, L.L.C. | 2.5% | 1,103,920 | 0 | 1,103,920 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP, L.L.C. | 0001879465 |
| Frazier Life Sciences Public Overage Fund, L.P. | 0.7% | 325,653 | 0 | 325,653 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P., GP of Frazier Life Sciences Public Overage Fund, L.P. | 0001913804 |
| FHMLSP Overage, L.P. | 0.7% | 325,653 | 0 | 325,653 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P. | 0001963247 |
| FHMLSP Overage, L.L.C. | 0.7% | 325,653 | 0 | 325,653 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C. | 0001963248 |
| Frazier Life Sciences X, L.P. | 12% | 5,219,440 | 0 | 5,219,440 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P. | 0001790879 |
| FHMLS X, L.P. | 12% | 5,219,440 | 0 | 5,219,440 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P. | 0001790880 |
| FHMLS X, L.L.C. | 12% | 5,219,440 | 0 | 5,219,440 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS X, L.L.C. | 0001790811 |
| Frazier Life Sciences XI, L.P. | 0% | 3,000 | 0 | 3,000 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P. | 0001911592 |
| FHMLS XI, L.P. | 0% | 3,000 | 0 | 3,000 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P. | 0001911580 |
| FHMLS XI, L.L.C. | 0% | 3,000 | 0 | 3,000 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS XI, L.L.C. | 0001911623 |
| James N. Topper | 12% | 5,219,440 | 0 | 5,219,440 | /s/ Steve R. Bailey | By Steve R. Bailey, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 | 0001341382 |
| Patrick J. Heron | 12% | 5,224,095 | 4,655 | 5,219,440 | /s/ Steve R. Bailey | By Steve R. Bailey, Attorney-in-Fact for Patrick J. Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 | 0001365617 |